Skip to main content
GEHC logo

GEHC · GE HealthCare Technologies Inc. · Earnings Call Transcripts & Audio

Track GEHC — free
Market Cap
$29.32B
Shares
454.89M

GE HealthCare Technologies Inc. Earnings Call Transcripts

Quarterly earnings calls for GE HealthCare Technologies Inc. (GEHC), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Conference
Investor event
2026-09-09
GE HealthCare Technologies Inc. (GEHC) September 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-07-29
GE HealthCare Technologies Inc. (GEHC) Q2 2026 Earnings Call Transcript
Confident tone PCS business challenges and strategic review Inflation and cost mitigation AI productivity
Results not yet reported
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-03
GE HealthCare Technologies Inc. (GEHC) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-04-29
GE HealthCare Technologies Inc. (GEHC) Q1 2026 Earnings Call Transcript
Cautious tone Inflation and input cost pressure Regional performance Segment reorganization
Revenue
$5.13B
▲ 7.4% YoY
Diluted EPS
$0.85
▼ 30.9% YoY
Gross margin
38.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-04
GE HealthCare Technologies Inc. (GEHC) Q4 2025 Earnings Call Transcript
Confident tone Order growth and backlog China and VBP tender environment 2026 financial guidance and setup
Revenue
$5.70B*
▲ 7.1% YoY
Gross margin
39.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-10-29
GE HealthCare Technologies Inc. (GEHC) Q3 2025 Earnings Call Transcript
Confident tone Flyrcado product launch and ramp Precision care strategy and innovation pipeline Margin performance and operational improvements
Revenue
$5.14B
▲ 5.8% YoY
Diluted EPS
$0.98
▼ 3.9% YoY
Gross margin
38.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-07-30
GE HealthCare Technologies Inc. (GEHC) Q2 2025 Earnings Call Transcript
Confident tone Capital equipment orders and backlog Imaging segment Tariff impact and mitigation
Revenue
$5.01B
▲ 3.5% YoY
Diluted EPS
$1.06
▲ 14% YoY
Gross margin
39.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-04-30
GE HealthCare Technologies Inc. (GEHC) Q1 2025 Earnings Call Transcript
Positive tone Tariffs and trade environment China and geographic dynamics Cash flow and capital allocation
Revenue
$4.78B
▲ 2.7% YoY
Diluted EPS
$1.23
▲ 51.9% YoY
Gross margin
42.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-13
GE HealthCare Technologies Inc. (GEHC) Q4 2024 Earnings Call Transcript
Confident tone 2025 guidance and capital equipment outlook Margin expansion and productivity China market
Revenue
$5.32B*
▲ 2.2% YoY
Gross margin
42.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-10-30
GE HealthCare Technologies Inc. (GEHC) Q3 2024 Earnings Call Transcript
Positive tone China market headwinds 2024 guidance and Q4 outlook Flyrcado (flurpiridaz) launch
Revenue
$4.86B
▲ 0.9% YoY
Diluted EPS
$1.02
▲ 24.4% YoY
Gross margin
41.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-07-31
GE HealthCare Technologies Inc. (GEHC) Q2 2024 Earnings Call Transcript
Positive tone China market headwinds and guidance cut Margin expansion and lean/Kaizen productivity Full-year guidance on revenue, EPS, and free cash flow
Revenue
$4.84B
▲ 0.5% YoY
Diluted EPS
$0.93
▲ 2.2% YoY
Gross margin
41.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-04-30
GE HealthCare Technologies Inc. (GEHC) Q1 2024 Earnings Call Transcript
Positive tone China market and stimulus Margin expansion and productivity Revenue and orders performance
Revenue
$4.65B
▼ 1.2% YoY
Diluted EPS
$0.81
▲ 97.6% YoY
Gross margin
40.9%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-06
GE HealthCare Technologies Inc. (GEHC) Q4 2023 Earnings Call Transcript
Confident tone Organic revenue growth and segment performance Margin expansion and productivity Backlog and orders momentum
Revenue
$5.21B*
▲ 5.4% YoY
Gross margin
41.4%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-10-31
GE HealthCare Technologies Inc. (GEHC) Q3 2023 Earnings Call Transcript
Revenue
$4.82B
▲ 5.4% YoY
Diluted EPS
$0.82
▼ 23.4% YoY
Gross margin
40.1%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-07-25
GE HealthCare Technologies Inc. (GEHC) Q2 2023 Earnings Call Transcript
Revenue
$4.82B
▲ 7.4% YoY
Diluted EPS
$0.91
▼ 15% YoY
Gross margin
40.3%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-04-25
GE HealthCare Technologies Inc. (GEHC) Q1 2023 Earnings Call Transcript
Revenue
$4.71B
▲ 8.4% YoY
Diluted EPS
$0.41
▼ 52.3% YoY
Gross margin
40.2%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-01-30
GE HealthCare Technologies Inc. (GEHC) Q4 2022 Earnings Call Transcript
Revenue
$4.94B*
Gross margin
39.1%
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–17 of 17 earnings calls
Key facts CIK 1932393 CUSIP 36266G107 13F (30d) 28 filings 22 filers Visit website Investor relations